Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
278.72%Stock Based Compensation Margin
VS
Market
Sector
Industry
History
$ 3.98Close
$ 3.57 - $ 19.8 52-Week Range
Ticker Information
Ticker
CLSDCompany Name
CLEARSIDE BIOMEDICAL INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCLEARSIDE BIOMEDICAL INC - Stock Based Compensation Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CLSD - SB Comp % Historical data
| Date | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
|---|---|---|---|
| 6/30/2025 | $ 1.34M | $ 3.75M | 278.72% |
| 3/31/2025 | $ 1.43M | $ 4.17M | 290.93% |
| 12/31/2024 | $ 1.66M | $ 4.51M | 271.21% |
| 9/30/2024 | $ 7.7M | $ 4.37M | 56.77% |
| 6/30/2024 | $ 7.52M | $ 4.28M | 56.91% |
| 3/31/2024 | $ 8.45M | $ 4.22M | 49.96% |
| 12/31/2023 | $ 8.23M | $ 4.2M | 51.08% |
| 9/30/2023 | $ 2.21M | $ 4.33M | 195.61% |
| 6/30/2023 | $ 1.62M | $ 4.33M | 267.31% |
| 3/31/2023 | $ 984K | $ 4.62M | 469.31% |
Key Performance Insights, Last 5 Years
- CLEARSIDE BIOMEDICAL INC's latest trailing twelve months (TTM) SB Comp % stands at 39.41%.
- Over the past 5 years, CLEARSIDE BIOMEDICAL INC's average SB Comp % has been 141.4%.
- The median SB Comp % for CLEARSIDE BIOMEDICAL INC during this period was 77.44%
- CLEARSIDE BIOMEDICAL INC reached its highest SB Comp % over the past 5 years at 469.31%.
- The lowest SB Comp % recorded by CLEARSIDE BIOMEDICAL INC in the same timeframe 17.09%
CLEARSIDE BIOMEDICAL INC's SB Comp % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp % Benchmarks
Similar metrics to SB Comp %:
- Stock Based Compensation - [Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
Definition of Stock Based Compensation Margin
[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].SB Comp. / Revenues
(=) SB Comp % SB Comp % for CLEARSIDE BIOMEDICAL INC is calculated as follows: SB Comp. [ $ 3.87M ] / Revenues [ $ 9.82M ]
(=) SB Comp % [ 39.41% ] CLSD - Stock Based Compensation Margin, Last 5 years
17.09%
Minimum
Dec 31, 2021
469.31%
Maximum
Mar 31, 2023
141.4%
Average
77.44%
Median
SB Comp % Benchmark AnalysisMarket
The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
| filtered constituents | 2.98K |
|---|---|
| min | -3.97% |
| max | 8.43% |
| average | 1.72% |
| median | 1.04% |
| std | 1.9% |